Interoperable Integration of a National Rare Disease Registry Into a Rare Eye Disease Data Warehouse: Implementation Study - Summary - MDSpire

Interoperable Integration of a National Rare Disease Registry Into a Rare Eye Disease Data Warehouse: Implementation Study

  • By

  • Camille Beluffi Marin

  • Marilyne Oswald

  • Laura Ratenet

  • Matthieu Stoll

  • Kirsley Chennen

  • Hélène Dollfus

  • May 26, 2026

  • 0 min

Share

Objective:

Emphasize the significance of automating data transfer for research.

Key Findings:
  • Include implications of findings for future research.
Interpretation:

Elaborate on how FREDDEX improves interoperability.

Limitations:
  • Expand on potential impacts of limitations on research outcomes.
Conclusion:

Reiterate the broader impact of FREDDEX on rare disease research.

Original Source(s)

Interoperable Integration of a National Rare Disease Registry Into a Rare Eye Disease Data Warehouse: Implementation Study

  • by Camille Beluffi Marin, Marilyne Oswald, Laura Ratenet, Matthieu Stoll, Kirsley Chennen, Hélène Dollfus

  • May 26, 2026

Related Content

Retinal Imaging AI May Flag Brain Health Risk

Authors said AI-driven retinal screening still lacks evidence that it improves patient outcomes.

SEE Program Strengthens Adherence

Personalized glaucoma coaching program boosts medication adherence and reduces stress in randomized trial

Could Red-Light Therapy Change Myopia Care? 

Across 28 trials, pediatric patients receiving therapy had less myopia progression over 12 months, though long-term risks remain under study.